Prevention of type 2 diabetes: issues and strategies for identifying persons for interventions.

Because of the ongoing worldwide diabetes epidemic and new evidence that type 2 diabetes can be prevented or delayed, we are compelled to implement prevention efforts. Health policy makers need to bridge the evidence gap left by prevention trials that did not include all groups at risk for developing diabetes. Intensive interventions may be appropriate for groups with similar risk as those studied in clinical trials, while less intense efforts may be considered for those groups that have not been studied. Factors such as structure of the health care system and individual social and economic situations may influence the implementation of prevention efforts. Currently, no universally validated and well-tested method exists to identify all people at high risk for developing diabetes. However, groups that will be targeted for prevention efforts can be identified through several reasonable strategies.

[1]  P. Wilson,et al.  Using metabolic syndrome traits for efficient detection of impaired glucose tolerance. , 2004, Diabetes care.

[2]  Bendix Carstensen,et al.  A Danish diabetes risk score for targeted screening: the Inter99 study. , 2004, Diabetes care.

[3]  Stephen Colagiuri,et al.  Screening for type 2 diabetes and impaired glucose metabolism: the Australian experience. , 2004, Diabetes care.

[4]  S. Genuth.  Lowering the criterion for impaired fasting glucose is in order. , 2003, Diabetes care.

[5]  H. Kahn,et al.  Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration. , 2003, The American journal of clinical nutrition.

[6]  Ping Zhang,et al.  Costs of screening for pre-diabetes among US adults: a comparison of different screening strategies. , 2003, Diabetes care.

[7]  Markolf Hanefeld,et al.  Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. , 2003, JAMA.

[8]  David Couper,et al.  Detection of undiagnosed diabetes and other hyperglycemia states: the Atherosclerosis Risk in Communities Study. , 2003, Diabetes care.

[9]  Jaakko Tuomilehto,et al.  The diabetes risk score: a practical tool to predict type 2 diabetes risk. , 2003, Diabetes care.

[10]  Edward J Boyko,et al.  Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans. , 2003, Diabetes care.

[11]  Robert M. Anderson,et al.  Prevention or delay of type 2 diabetes. , 2004, Diabetes care.

[12]  S. Saydah,et al.  Projected impact of implementing the results of the diabetes prevention program in the U.S. population. , 2002, Diabetes care.

[13]  J. Shaw,et al.  Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[14]  T. Buchanan,et al.  Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. , 2002, Diabetes.

[15]  M. Laakso,et al.  Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial , 2002, The Lancet.

[16]  S. Haffner,et al.  Identification of Persons at High Risk for Type 2 Diabetes Mellitus: Do We Need the Oral Glucose Tolerance Test? , 2002, Annals of Internal Medicine.

[17]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[18]  Lawrence A Leiter,et al.  Diabetes Screening in Canada (DIASCAN) Study: prevalence of undiagnosed diabetes and glucose intolerance in family physician offices. , 2001, Diabetes care.

[19]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[20]  J M Dekker,et al.  Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. , 2001, JAMA.

[21]  E. Feskens,et al.  Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. , 2001, Archives of internal medicine.

[22]  M. Engelgau,et al.  Screening for type 2 diabetes. , 2000, Diabetes care.

[23]  B. Howard,et al.  Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study , 1997, Diabetes Care.